Kallmann (KAL1) and Steroid Sulphatase Deficiency (STS) Probe Combination
Kallmann syndrome (KS) is a developmental disease characterised by olfactory deficiency3 and hypogonadotrophic hypogonadism (HH), which is responsible for the absence of spontaneous puberty1.
Kallmann syndrome is a heterogeneous developmental genetic disorder affecting approximately 1 in 8,000 males and 1 in 40,000 females2. Reports indicate three modes of inheritance: X-linked, autosomal dominant and autosomal recessive1,4.
It has been shown that mutations in the KAL1 gene on Xp22.3 result in the X-linked form of KS5. KAL1 consists of 14 exons and extends over 200kb and abnormalities of KAL1 reported in patients with KS include missense and nonsense mutations, splice site mutations, intragenic deletions and submicroscopic chromosomal deletions involving the entire KAL1 gene7.
Steroid Sulphatase Deficiency (STS) (also known as X-linked Ichthyosis)8 is the second most common type of ichthyosis and one of the most frequent human enzyme deficiency disorders.
Deficiency of the STS enzyme is known to be responsible for dark, adhesive and regular scaling of the skin9. The gene encoding this protein maps to the distal short arm of chromosome X, which escapes X-chromosome inactivation and has the highest ratio of chromosomal deletions among all genetic disorders10. Complete deletions of the STS gene have been found in more than 90% of patients11. The deletions can extend to involve neighbouring genes, causing contiguous gene defects. Therefore, STS may be associated with KS12.
1. Kallmann FJ et al., Am J Ment Defic 1944;48:203-36
2. Hu Y et al., Int J Biochem Cell Biol 2003;35:1157-62
3. Hockaday TD, Postgrad Med J 1966;42:572-4
4. White BJ, Am J Med Genet 1983;15:417-35
5. Hardelin JP et al., Human Mol Genet 1993;2:373-7
6. Del Castillo I et al., Nat Genet 1992;2:305-10
7. Izumi Y et al., Endocr J 2001;48:143-9
8. Wells RS et al., Arch Dermatol 1965;92(1):1-6
9. Valdes-Flores M et al., J Invest Dermatol. 2001;116(3):456-8
10. Hernandez-Martin A et al., Br J Dermatol 1999;141(4):617-27
11. Hazan C et al., Dermatology Online 2005;11(4):12
12. Paige DG et al., Br J Dermatol 1994;131(5):622-9
This product is intended to be used on Carnoy’s solution (3:1 methanol/acetic acid) fixed peripheral blood samples.